Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Cathepsin B cleavable novel prodrug Ac-Phe-Lys-PABC-ADM enhances efficacy at reduced toxicity in treating gastric cancer peritoneal carcinomatosis: An experimental study.
Shao LH, Liu SP, Hou JX, Zhang YH, Peng CW, Zhong YJ, Liu X, Liu XL, Hong YP, Firestone RA, Li Y.
Cancer. 2012 Jun 1;118(11):2986-96. doi: 10.1002/cncr.26596. Epub 2011 Oct 17.
Related citations
Error occurred: cannot get document summary
Proper selection and classification criteria are necessary in the evaluation of the new TNM staging system for gastric cancer.
Marrelli D, Roviello F.
Cancer. 2012 Mar 1;118(5):1466; author reply 1466-7. doi: 10.1002/cncr.26331. Epub 2011 Jul 15. No abstract available.
Characterization of the gene structure, functional significance, and clinical application of RNF180, a novel gene in gastric cancer.
Cheung KF, Lam CN, Wu K, Ng EK, Chong WW, Cheng AS, To KF, Fan D, Sung JJ, Yu J.
Cancer. 2012 Feb 15;118(4):947-59. doi: 10.1002/cncr.26189. Epub 2011 Jun 29.
Zinc finger E-box binding factor 1 plays a central role in regulating Epstein-Barr virus (EBV) latent-lytic switch and acts as a therapeutic target in EBV-associated gastric cancer.
Zhao J, Jin H, Cheung KF, Tong JH, Zhang S, Go MY, Tian L, Kang W, Leung PP, Zeng Z, Li X, To KF, Sung JJ, Yu J.
Cancer. 2012 Feb 15;118(4):924-36. doi: 10.1002/cncr.26184. Epub 2011 Jun 29.
Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification.
Rausei S, Dionigi G, Boni L.
Cancer. 2011 Jun 15;117(12):2823-4; author reply 2824. doi: 10.1002/cncr.25801. Epub 2011 Jan 24. No abstract available.
A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expression for personalized therapy.
Jeung HC, Rha SY, Im CK, Shin SJ, Ahn JB, Yang WI, Roh JK, Noh SH, Chung HC.
Cancer. 2011 May 15;117(10):2050-7. doi: 10.1002/cncr.25729. Epub 2010 Nov 29.
Fibroblast growth factor receptor 4 regulates proliferation and antiapoptosis during gastric cancer progression.
Ye YW, Zhou Y, Yuan L, Wang CM, Du CY, Zhou XY, Zheng BQ, Cao X, Sun MH, Fu H, Shi YQ.
Cancer. 2011 Dec 1;117(23):5304-13. doi: 10.1002/cncr.26207. Epub 2011 May 12.
Increased genetic susceptibility to intestinal-type gastric cancer is associated with increased activity of the RUNX3 distal promoter.
Lim B, Ju H, Kim M, Kang C.
Cancer. 2011 Nov 15;117(22):5161-71. doi: 10.1002/cncr.26161. Epub 2011 Apr 26.
Prospective evaluation of the reliability, validity, and minimally important difference of the functional assessment of cancer therapy-gastric (FACT-Ga) quality-of-life instrument.
Garland SN, Pelletier G, Lawe A, Biagioni BJ, Easaw J, Eliasziw M, Cella D, Bathe OF.
Cancer. 2011 Mar 15;117(6):1302-12. doi: 10.1002/cncr.25556. Epub 2010 Oct 19.
Improved survival in patients with lymph node-positive gastric cancer who received preoperative radiation: an analysis of the Surveillance, Epidemiology, and End Results database.
Shridhar R, Dombi GW, Finkelstein SE, Meredith KL, Hoffe SE.
Cancer. 2011 Sep 1;117(17):3908-16. doi: 10.1002/cncr.25995. Epub 2011 Mar 1.
Germline mutations of the E-cadherin gene in families with inherited invasive lobular breast carcinoma but no diffuse gastric cancer.
Xie ZM, Li LS, Laquet C, Penault-Llorca F, Uhrhammer N, Xie XM, Bignon YJ.
Cancer. 2011 Jul 15;117(14):3112-7. doi: 10.1002/cncr.25876. Epub 2011 Jan 26.
Insulin-like growth factor-I receptor blockade reduces tumor angiogenesis and enhances the effects of bevacizumab for a human gastric cancer cell line, MKN45.
Li H, Adachi Y, Yamamoto H, Min Y, Ohashi H, Ii M, Arimura Y, Endo T, Lee CT, Carbone DP, Imai K, Shinomura Y.
Cancer. 2011 Jul 15;117(14):3135-47. doi: 10.1002/cncr.25893. Epub 2011 Jan 24.
Validation of the seventh edition of the american joint committee on cancer TNM staging system for gastric cancer.
Jung H, Lee HH, Song KY, Jeon HM, Park CH.
Cancer. 2011 Jan 11. [Epub ahead of print]
Evaluation of the seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification.
Ahn HS, Lee HJ, Hahn S, Kim WH, Lee KU, Sano T, Edge SB, Yang HK.
Cancer. 2010 Dec 15;116(24):5592-8. doi: 10.1002/cncr.25550. Epub 2010 Aug 24.
Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography.
Patnana SV, Murthy SB, Xiao L, Rohren E, Hofstetter WL, Swisher SG, Liao Z, Lee JH, Bhutani MS, Macapinlac HA, Wang X, Ajani JA.
Cancer. 2010 Oct 1;116(19):4487-94.
Cost-effectiveness of treatment and endoscopic surveillance of precancerous lesions to prevent gastric cancer.
Yeh JM, Hur C, Kuntz KM, Ezzati M, Goldie SJ.
Cancer. 2010 Jun 15;116(12):2941-53.
SERPINE1 intron polymorphisms affecting gene expression are associated with diffuse-type gastric cancer susceptibility.
Ju H, Lim B, Kim M, Noh SM, Kim WH, Ihm C, Choi BY, Kim YS, Kang C.
Cancer. 2010 Sep 15;116(18):4248-55.
Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.
Minn AY, Hsu A, La T, Kunz P, Fisher GA, Ford JM, Norton JA, Visser B, Goodman KA, Koong AC, Chang DT.
Cancer. 2010 Aug 15;116(16):3943-52.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on